Izrael - angol - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - capsules - oseltamivir as phosphate 30 mg - oseltamivir - oseltamivir - treatment of influenza : treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. prophylaxis of influenza : post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older.

Izrael - angol - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - capsules - oseltamivir as phosphate 45 mg - oseltamivir - oseltamivir - treatment of influenza : treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. prophylaxis of influenza : post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older.

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ranbaxy (malaysia) sdn. bhd. - oseltamivir phosphate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 59.1 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: titanium dioxide; croscarmellose sodium; povidone; sodium stearylfumarate; gelatin; pregelatinised maize starch; iron oxide black; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 39.4 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; iron oxide red; povidone; sodium stearylfumarate; iron oxide yellow; croscarmellose sodium; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 98.5 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: iron oxide red; croscarmellose sodium; purified talc; iron oxide black; gelatin; titanium dioxide; pregelatinised maize starch; iron oxide yellow; sodium stearylfumarate; povidone; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

camber laboratories sdn. bhd. - oseltamivir phosphate -

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

camber laboratories sdn. bhd. - oseltamivir phosphate -

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

camber laboratories sdn. bhd. - oseltamivir phosphate -

Dél-afrikai Köztársaság - angol - South African Health Products Regulatory Authority (SAHPRA)

hetero drugs south africa (pty) ltd - powder - 6,0 mg - each 1,0 ml solution contains oseltamivir phosphate equivalent to oseltamavir 6,0 mg